Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Patients With Breast Cancer: Estimates From SEER-Medicare Data

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2016.0007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Dysphagia Prevalence and Associated Survival Differences in Older Patients With Lung Cancer: A SEER-Medicare Population-Based Study

Journal of Geriatric Oncology
GerontologyGeriatricsOncology
2020English

Long-Term Medical-Care Costs Related to Prostate Cancer: Estimates From Linked SEER-Medicare Data

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2010English

Methylphenidate Off-Label Use and Safety

SpringerPlus
Multidisciplinary
2014English

Mortality Among Women Diagnosed With Stage II or III Breast Cancer Based on SEER-Medicare Data.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Effect of Chemotherapeutic Agents Upon Microorganisms Isolated From Cancer Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1972English

Off-Label Use in Lymphoma Patients in Switzerland

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Health Disparities in Staging of SEER-Medicare Prostate Cancer Patients in the United States

Urology
Urology
2010English

Early Estimates of SEER Cancer Incidence, 2014

Cancer
Cancer ResearchOncology
2017English

Perioperative Complications in Patients With Anthracycline Chemotherapeutic Agents

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy